- Home
- EMKR vs MTEM Comparison
EMKR vs MTEM Comparison
Compare EMKR & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMKR
- MTEM
- Stock Information
- Founded
- EMKR 1984
- MTEM 2001
- Country
- EMKR United States
- MTEM United States
- Employees
- EMKR N/A
- MTEM N/A
- Industry
- EMKR Semiconductors
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EMKR Technology
- MTEM Health Care
- Exchange
- EMKR Nasdaq
- MTEM Nasdaq
- Market Cap
- EMKR 9.5M
- MTEM 9.7M
- IPO Year
- EMKR 1997
- MTEM N/A
- Fundamental
- Price
- EMKR $2.33
- MTEM $0.75
- Analyst Decision
- EMKR Buy
- MTEM
- Analyst Count
- EMKR 2
- MTEM 0
- Target Price
- EMKR $3.00
- MTEM N/A
- AVG Volume (30 Days)
- EMKR 2.0M
- MTEM 13.3M
- Earning Date
- EMKR 12-10-2024
- MTEM 11-11-2024
- Dividend Yield
- EMKR N/A
- MTEM N/A
- EPS Growth
- EMKR N/A
- MTEM N/A
- EPS
- EMKR N/A
- MTEM N/A
- Revenue
- EMKR $90,961,000.00
- MTEM $25,470,000.00
- Revenue This Year
- EMKR N/A
- MTEM N/A
- Revenue Next Year
- EMKR $7.07
- MTEM N/A
- P/E Ratio
- EMKR N/A
- MTEM N/A
- Revenue Growth
- EMKR 413.79
- MTEM N/A
- 52 Week Low
- EMKR $0.78
- MTEM $0.30
- 52 Week High
- EMKR $7.20
- MTEM $6.48
- Technical
- Relative Strength Index (RSI)
- EMKR 67.47
- MTEM 39.63
- Support Level
- EMKR $2.07
- MTEM $0.31
- Resistance Level
- EMKR $2.54
- MTEM $1.34
- Average True Range (ATR)
- EMKR 0.16
- MTEM 0.14
- MACD
- EMKR -0.02
- MTEM -0.06
- Stochastic Oscillator
- EMKR 55.32
- MTEM 38.14
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.